A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non-Small Cell Lung Cancer with a KRAS Mutation

A.M.C. Dingemans, W.W. Mellema, H.J.M. Groen, A.W. van Wijk, S.A. Burgers, P.W. Kunst, E. Thunnissen, D.A.M. Heideman, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)743-751
JournalClinical Cancer Research
Issue number3
Publication statusPublished - 2013

Cite this